Respiratory Health

Departmental Publication (Statistics)
Ministry of Justice

Apr. 25 2024

Source Page: Safety in custody: quarterly update to December 2023
Document: (PDF)

Found: Stronger irritants that may burn the skin, eyes, and/or respiratory tract e.g., bleach, floor cleaner

Scottish Government Publication (Advice and guidance)
Local Government and Housing Directorate

Apr. 25 2024

Source Page: Scottish Government Planning Guidance - Local living and 20 minute neighbourhoods
Document: Scottish Government Planning Guidance: Local living and 20 minute neighbourhoods (PDF)

Found: Reduced health inequalities The World Health Organisation3 definition of health is ‘a state of complete

Commons Chamber
Business of the House - Thu 25 Apr 2024
Leader of the House

Mentions:
1: Bob Blackman (Con - Harrow East) On Thursday, we have debates on global health agencies and on Global Intergenerational Week. - Speech Link
2: Deidre Brock (SNP - Edinburgh North and Leith) Since 2021, £200 million will have been spent on just one export health certificate. - Speech Link
3: Andrew Bridgen (Ind - North West Leicestershire) response and trends in excess deaths, I asked whether it is now accepted that it was a mistake to give the respiratory - Speech Link
4: Penny Mordaunt (Con - Portsmouth North) I will ensure that the Department of Health and Social Care has heard what he has said. - Speech Link

Written Question

Health: Men

Thursday 25th April 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has she made of the potential merits of a men's health strategy for the economy.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Whilst no specific assessment has been made, we are already taking action to address the health issues that disproportionately impact men. This includes through policies announced on International Men’s Day, such as the appointment of a Men’s Health Ambassador, to raise the profile of men’s health issues. The Major Conditions Strategy will also focus on improving health outcomes linked to major condition areas like cancer, cardiovascular, and chronic respiratory diseases that disproportionately impact men.

Written Question

Respiratory Syncytial Virus

Thursday 25th April 2024

Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what data they are gathering on countries currently implementing immunisation programmes for infant respiratory syncytial virus regarding (1) acceptance and uptake, and (2) hospitalisations.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK Health Security Agency continues to monitor international reporting. In the United States, as of 31 January 2024, maternal immunisation was 17.9%. By February 2024, 43% of infants under eight months old had received a dose of nirsevimab.

In Galicia, Spain, 92.9% of 5,357 infants born between 25 September 2023 and 4 February 2024 had nirsevimab, plus 79.7% of 5,823 in a catch-up programme. The peak of hospitalisation rate in infants under six months old was 102 per 100,000, for season 2023 to 2024 during the week starting 27 November 2023 compared to a median of 776 for seasons 2017 to 2018, 2018 to 2019 and 2019 to 2020, peaking during the first week of January 2024.

In Luxembourg, 84% of 1,524 infants born in hospital between early October and mid-December 2023 received nirsevimab. Luxembourg observed a decrease in hospitalisation in infants under six months old of 69% between the 2022 to 2023 and 2023 to 2024 respiratory syncytial virus seasons.

Select Committee